Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
08/19/2003 | US6607742 Suppository composition which is a spray-dried suspension of an acid-labile proton pump inhibitor in a solvent solution of a sterol and polymer |
08/19/2003 | US6607741 Conjugates of sodium channel blockers and methods of using the same |
08/19/2003 | US6607382 Methods and systems for concurrent tooth repositioning and substance delivery |
08/19/2003 | CA2260337C Therapeutic agents |
08/19/2003 | CA2100777C Pharmaceutical composition containing granisetron and dexamethasone |
08/19/2003 | CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
08/14/2003 | WO2003067221A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
08/14/2003 | WO2003067209A2 Ligands to enhance cellular uptake of biomolecules |
08/14/2003 | WO2003066892A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
08/14/2003 | WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/14/2003 | WO2003066845A2 Bacteriophage lysin |
08/14/2003 | WO2003066840A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
08/14/2003 | WO2003066824A2 Albumin-fused kunitz domain peptides |
08/14/2003 | WO2003066822A2 Truncated aggrecanase molecules |
08/14/2003 | WO2003066806A2 Therapeutic use of aziridino compounds |
08/14/2003 | WO2003066672A1 Peptides |
08/14/2003 | WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency |
08/14/2003 | WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
08/14/2003 | WO2003066635A1 Piperidine derivatives |
08/14/2003 | WO2003066630A2 Quinolinone derivatives for treating cell proliferation related disorders |
08/14/2003 | WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins |
08/14/2003 | WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent |
08/14/2003 | WO2003066618A1 Cytoprotective benzofuran derivatives |
08/14/2003 | WO2003066604A2 Novel aryl- and heteroarylpiperazines |
08/14/2003 | WO2003066595A2 2 - piperazine - pyridines useful for treating pain |
08/14/2003 | WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
08/14/2003 | WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
08/14/2003 | WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
08/14/2003 | WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases |
08/14/2003 | WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
08/14/2003 | WO2003066572A1 Polyamine compounds and compositions for use in conjunction with cancer therapy |
08/14/2003 | WO2003066103A1 Pharmaceutical compositions for hepatitis c viral protease inhibitors |
08/14/2003 | WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
08/14/2003 | WO2003066087A2 Kinases involved in the regulation of energy homeostasis |
08/14/2003 | WO2003066085A1 Albumin-fused anti-angiogenesis peptides |
08/14/2003 | WO2003066078A1 Hiv inhibiting proteins |
08/14/2003 | WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
08/14/2003 | WO2003066075A1 Medication for curing dysbacteriosis and the method for production thereof |
08/14/2003 | WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
08/14/2003 | WO2003066062A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera |
08/14/2003 | WO2003066060A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
08/14/2003 | WO2003066058A1 Pharmaceutical composition for regeneration of cirrhotic liver |
08/14/2003 | WO2003066055A1 Quinoline derivatives as npy antagonists |
08/14/2003 | WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
08/14/2003 | WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss |
08/14/2003 | WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
08/14/2003 | WO2003066037A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases |
08/14/2003 | WO2003066025A1 Clear micellized formulations of beta-carotene for treating leukoplakia |
08/14/2003 | WO2003066003A2 Anti-pathogen treatements |
08/14/2003 | WO2003065999A2 Proliferated cell lines and uses thereof |
08/14/2003 | WO2003065989A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
08/14/2003 | WO2003065987A2 Granzyme b inhibitors |
08/14/2003 | WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
08/14/2003 | WO2003065981A2 Therapeutic use for lp229, in particular for wound healing |
08/14/2003 | WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
08/14/2003 | WO2003045437A8 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
08/14/2003 | WO2003037335A8 5-heteroatom-substituted pyrazoles |
08/14/2003 | WO2003035177A3 Optimal polymer mixtures for gastric retentive tablets |
08/14/2003 | WO2003031568A8 Intracellular signaling molecules |
08/14/2003 | WO2003029433A3 Chimeric viral vectors for gene therapy |
08/14/2003 | WO2003017935A3 Human antibodies specific for interleukin 15 (il-15) |
08/14/2003 | WO2003013558A8 Treatment of radiation-induced diarrhea with probiotics |
08/14/2003 | WO2003002129B1 Use of sulodexide for the treatment of inflammatory bowel disease |
08/14/2003 | WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
08/14/2003 | WO2002092849A3 Methods |
08/14/2003 | WO2002081430A3 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors |
08/14/2003 | WO2002064083A3 Synthesis of 3-amino-thalidomide and its enantiomers |
08/14/2003 | WO2002057453A3 Polypetides and nucleic acids encoding same |
08/14/2003 | WO2002055560A3 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
08/14/2003 | WO2002029055A3 Carbohydrate-associated proteins |
08/14/2003 | WO2002015933A3 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
08/14/2003 | WO2001092527A3 Regulators of apoptosis |
08/14/2003 | US20030153766 Dissolving Lansoprazole hydrate in an organic solvent solution or suspension and crystalling and separating a Lansoprazole enantiomorph; resolution; purification; antiulcer agents |
08/14/2003 | US20030153755 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases |
08/14/2003 | US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
08/14/2003 | US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors |
08/14/2003 | US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease |
08/14/2003 | US20030153605 Enzyme inhibitors of nitric oxide synthase |
08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
08/14/2003 | US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders |
08/14/2003 | US20030153578 CCR-3 receptor antagonists (I) |
08/14/2003 | US20030153576 Such as amino-indazoles for treatment of central nervous system disorders |
08/14/2003 | US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors |
08/14/2003 | US20030153573 Novel N-substituted 4-((-4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
08/14/2003 | US20030153569 Novel pyrazole and pyrazoline substituted compounds |
08/14/2003 | US20030153568 Serine/threonine and tyrosine kinases inhibitors |
08/14/2003 | US20030153563 CRF receptor antagonists and methods relating thereto |
08/14/2003 | US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides |
08/14/2003 | US20030153558 Immunomodulators and/or inhibiting cytokine release |
08/14/2003 | US20030153553 Quinoline derivatives |
08/14/2003 | US20030153536 Compounds and methods of treating transplant rejection |
08/14/2003 | US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states |
08/14/2003 | US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex |
08/14/2003 | US20030153513 Preventives or remedies for obesity or fatty liver |
08/14/2003 | US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides |
08/14/2003 | US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents |
08/14/2003 | US20030153075 TGF-beta-specific covalently closed antisense molecule |
08/14/2003 | US20030153073 Expansion of T cells in vitro and expanded T cell populations |
08/14/2003 | US20030153018 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710 |
08/14/2003 | US20030152664 Microbiocides fatty acid mixed with feed |